The Researchers of this study previously documented that Hyperbaric Oxygen therapy (HBOT) was able to help provide "significant improvements in cognitive, psychiatric, fatigue, sleep, and pain symptoms" for those individuals suffering from Long COVID syndrome (LCS) In this follow up study, researchers wanted to determine if the reported benefits were long-lasting, so they required a full 40 hour couses of HBOT along with a one-year minimum follow up evaluation for all participants. The follow up results confirmed that alll the clinical improvements gained by HBOT were persistent even 1 year after the last HBOT session"<view study> Read Less

An estimated 15.1% of individuals suffer from Long Covid Syndrome (LCS) 3 months following severe SARS-CoV-2 infection, with symptoms continuing past 12 months. LCS symptoms commonly include persistent fatigue, mood swings, body pain, cognitive impairment, and ongoing respiratory problems. Other persistent symptoms can include headaches, mental disorders, gut issues, insomnia, hair loss, and smell/taste dysfunction. Treatment options are limited to symptomatic measures, and no specific medication has been established. Previous studies have shown that just 10 sessions of HBOT at 2.4 ATA caused a statistically significant improvement of fatigue, global cognition, executive function, attention, information processing and verbal function. In this study, 18 patients (aged 18-90) were given a short course of 10 hyperbaric sessions at 2.2 ATA and were followed up 3 months later for evaluation of LCS. The results were very promising and documented significant improvements in energy levels, physical functioning, emotional well being, social functioning and improvement in limitation of activities <view study> Read Less

COVID-19 brings along an ever-growing concern for infected patients who have recovered from the acute phase of the viral infection. These individuals are now suffering from the long-term adverse health effects as a result. These long-term complications (aka long COVID-19), have been shown to affect everyone; including the chronically-sick, the healthy, and even the professional athlete. “Long COVID-19 patients show systemic inflammation and persistent symptoms such as fatigue and malaise, profoundly affecting their quality of life” Hyperbaric oxygen therapy (HBOT) has been shown to help the body produce a strong anti-inflammatory response that may be able to help combat Long Covid and provide symptomatic relief. This study evaluated 5 subjects, (2 patients and 3 athletes) undergoing HBOT for 30 sessions and all 5 showed attenuation of inflammatory biomarkers, particularity the 2 athletes. “From this preliminary observation, HBOT could be considered a potential treatment for long COVID-19 patients.” <view study> Read Less

In this study, Post COVID patients were evaluated for symptoms of muscle and joint pain. Following the administration of hyperbaric oxygen therapy, ALL patients reported improvements! Researchers of this study concluded: "The results suggest that HBO2 helped to improve symptom scores, reduce the length of time of symptoms, and improved the quality of life. More detailed and randomized studies are needed to confirm the results in this report" <view study> Read Less

Persistent physical, neurocognitive, and neuropsychological symptoms are becoming more commonly seen following SARS-CoV-2 infection infections. Hyperbaric oxygen therapy (HBOT) has shown promising results by providing a wide range of physiological benefits. In this study, a simple course of 40 HBOT sessions provided significant improvements; mainly in sleep, psychiatric symptoms, and pain.“These results indicate that HBOT can induce neuroplasticity and improve cognitive, psychiatric, fatigue, sleep and pain symptoms of patients suffering from post-COVID-19 condition”. <view study> Read Less